Sarah J Spence, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autistic Disorder | 19 | 2023 | 1185 | 1.700 |
Why?
|
| Child Development Disorders, Pervasive | 8 | 2013 | 615 | 1.010 |
Why?
|
| Epilepsy | 7 | 2016 | 3310 | 0.520 |
Why?
|
| Infant, Premature, Diseases | 1 | 2020 | 706 | 0.490 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2011 | 63 | 0.400 |
Why?
|
| Apraxias | 1 | 2011 | 64 | 0.390 |
Why?
|
| Chromosomes, Human, Pair 16 | 3 | 2016 | 354 | 0.340 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2009 | 42 | 0.330 |
Why?
|
| Chromosome Disorders | 3 | 2016 | 514 | 0.330 |
Why?
|
| Child Behavior | 2 | 2011 | 839 | 0.330 |
Why?
|
| Chromosome Duplication | 3 | 2016 | 74 | 0.310 |
Why?
|
| Complementary Therapies | 1 | 2011 | 486 | 0.300 |
Why?
|
| Behavior Therapy | 2 | 2011 | 865 | 0.280 |
Why?
|
| Genetic Linkage | 2 | 2007 | 2421 | 0.240 |
Why?
|
| Child | 24 | 2023 | 77709 | 0.230 |
Why?
|
| Chromosome Deletion | 4 | 2016 | 1401 | 0.220 |
Why?
|
| Chromosome Aberrations | 3 | 2017 | 1813 | 0.220 |
Why?
|
| Microarray Analysis | 1 | 2023 | 767 | 0.190 |
Why?
|
| Vigabatrin | 1 | 2001 | 92 | 0.180 |
Why?
|
| Phenotype | 7 | 2017 | 16365 | 0.180 |
Why?
|
| Anticonvulsants | 2 | 2014 | 1916 | 0.150 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2020 | 406 | 0.150 |
Why?
|
| Language | 1 | 2006 | 1471 | 0.150 |
Why?
|
| Child, Preschool | 15 | 2018 | 41006 | 0.140 |
Why?
|
| Tetrahydrofolates | 1 | 2016 | 61 | 0.140 |
Why?
|
| Electroencephalography | 2 | 2016 | 6150 | 0.130 |
Why?
|
| Genetic Testing | 3 | 2023 | 3444 | 0.130 |
Why?
|
| Eye Diseases | 1 | 2001 | 669 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2017 | 17446 | 0.130 |
Why?
|
| Family | 3 | 2023 | 3147 | 0.120 |
Why?
|
| Developmental Disabilities | 3 | 2016 | 1456 | 0.110 |
Why?
|
| DNA Copy Number Variations | 3 | 2017 | 1941 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2015 | 658 | 0.110 |
Why?
|
| Trisomy | 1 | 2014 | 266 | 0.110 |
Why?
|
| Comorbidity | 6 | 2016 | 10388 | 0.110 |
Why?
|
| Mental Disorders | 1 | 2011 | 6600 | 0.100 |
Why?
|
| Social Behavior | 2 | 2010 | 1127 | 0.100 |
Why?
|
| Humans | 35 | 2023 | 744343 | 0.090 |
Why?
|
| Social Adjustment | 2 | 2010 | 631 | 0.090 |
Why?
|
| Child Language | 1 | 2010 | 64 | 0.090 |
Why?
|
| Databases, Genetic | 1 | 2017 | 1783 | 0.090 |
Why?
|
| Head | 2 | 2013 | 880 | 0.090 |
Why?
|
| Child Behavior Disorders | 1 | 2013 | 807 | 0.080 |
Why?
|
| Syndrome | 3 | 2014 | 3251 | 0.080 |
Why?
|
| Cognition | 2 | 2016 | 6770 | 0.070 |
Why?
|
| Chromosome Mapping | 2 | 2007 | 4740 | 0.070 |
Why?
|
| Methylation | 1 | 2009 | 1106 | 0.070 |
Why?
|
| Parent-Child Relations | 1 | 2010 | 747 | 0.070 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2012 | 1953 | 0.060 |
Why?
|
| Mitochondrial Diseases | 1 | 2009 | 320 | 0.060 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2005 | 202 | 0.060 |
Why?
|
| Twin Studies as Topic | 1 | 2004 | 105 | 0.060 |
Why?
|
| Data Collection | 1 | 2014 | 3341 | 0.060 |
Why?
|
| Communication | 2 | 2010 | 3749 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2009 | 2187 | 0.060 |
Why?
|
| Genotype | 5 | 2016 | 12951 | 0.050 |
Why?
|
| Infant | 3 | 2020 | 35136 | 0.050 |
Why?
|
| Age of Onset | 1 | 2009 | 3271 | 0.050 |
Why?
|
| Gene Dosage | 1 | 2007 | 1252 | 0.050 |
Why?
|
| Inheritance Patterns | 1 | 2004 | 340 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2020 | 25625 | 0.050 |
Why?
|
| Seizures | 1 | 2014 | 2859 | 0.050 |
Why?
|
| Neurologic Examination | 1 | 2004 | 930 | 0.050 |
Why?
|
| Medical History Taking | 1 | 2004 | 783 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2010 | 2576 | 0.040 |
Why?
|
| Databases as Topic | 1 | 2001 | 475 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2007 | 2617 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2023 | 643 | 0.040 |
Why?
|
| Parents | 2 | 2010 | 3407 | 0.040 |
Why?
|
| Genome | 1 | 2007 | 1808 | 0.040 |
Why?
|
| Young Adult | 5 | 2016 | 56430 | 0.040 |
Why?
|
| Physical Examination | 1 | 2004 | 1237 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 12261 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2016 | 6882 | 0.040 |
Why?
|
| Male | 15 | 2018 | 350118 | 0.040 |
Why?
|
| Polymorphism, Genetic | 2 | 2005 | 4328 | 0.040 |
Why?
|
| Genome, Human | 2 | 2007 | 4420 | 0.030 |
Why?
|
| Neuropsychological Tests | 3 | 2016 | 6993 | 0.030 |
Why?
|
| Asperger Syndrome | 2 | 2007 | 63 | 0.030 |
Why?
|
| Female | 14 | 2018 | 380194 | 0.030 |
Why?
|
| Adolescent | 8 | 2016 | 85781 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2004 | 2421 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 2017 | 655 | 0.030 |
Why?
|
| Visual Fields | 1 | 2001 | 1047 | 0.030 |
Why?
|
| Nervous System Malformations | 1 | 2016 | 247 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2005 | 2408 | 0.030 |
Why?
|
| Population | 1 | 2013 | 142 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2014 | 373 | 0.030 |
Why?
|
| Gene Order | 1 | 2012 | 176 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 1526 | 0.030 |
Why?
|
| Language Development | 1 | 2013 | 187 | 0.030 |
Why?
|
| Inpatients | 1 | 2023 | 2518 | 0.030 |
Why?
|
| Sex Ratio | 1 | 2012 | 110 | 0.030 |
Why?
|
| Microcephaly | 1 | 2016 | 432 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2012 | 505 | 0.020 |
Why?
|
| Case-Control Studies | 4 | 2016 | 21746 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 9438 | 0.020 |
Why?
|
| Risk Factors | 4 | 2013 | 72290 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2014 | 63114 | 0.020 |
Why?
|
| Folic Acid | 1 | 2016 | 1300 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 12959 | 0.020 |
Why?
|
| Internet | 1 | 2001 | 3064 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 12072 | 0.020 |
Why?
|
| Cerebellum | 1 | 2016 | 1488 | 0.020 |
Why?
|
| Schizophrenic Psychology | 1 | 2016 | 1678 | 0.020 |
Why?
|
| Brain | 2 | 2013 | 26385 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2007 | 3920 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2016 | 40561 | 0.020 |
Why?
|
| Gene Frequency | 2 | 2004 | 3588 | 0.020 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2007 | 117 | 0.020 |
Why?
|
| Lod Score | 1 | 2007 | 614 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2007 | 295 | 0.020 |
Why?
|
| Terbutaline | 1 | 2005 | 24 | 0.020 |
Why?
|
| Tocolytic Agents | 1 | 2005 | 25 | 0.020 |
Why?
|
| DNA Mutational Analysis | 2 | 2005 | 4186 | 0.020 |
Why?
|
| Fragile X Syndrome | 1 | 2007 | 115 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 2804 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2007 | 329 | 0.020 |
Why?
|
| Prevalence | 2 | 2013 | 15226 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 13989 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5319 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2007 | 1375 | 0.020 |
Why?
|
| Twins, Dizygotic | 1 | 2005 | 236 | 0.020 |
Why?
|
| Adult | 6 | 2016 | 214055 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2007 | 802 | 0.020 |
Why?
|
| Americas | 1 | 2004 | 111 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2004 | 12208 | 0.010 |
Why?
|
| Obstetric Labor, Premature | 1 | 2005 | 279 | 0.010 |
Why?
|
| Markov Chains | 1 | 2007 | 969 | 0.010 |
Why?
|
| Age Factors | 2 | 2013 | 18370 | 0.010 |
Why?
|
| Siblings | 1 | 2007 | 854 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2013 | 2616 | 0.010 |
Why?
|
| Mutation | 1 | 2007 | 29786 | 0.010 |
Why?
|
| Italy | 1 | 2004 | 832 | 0.010 |
Why?
|
| Alanine | 1 | 2004 | 572 | 0.010 |
Why?
|
| Models, Psychological | 1 | 2006 | 811 | 0.010 |
Why?
|
| Skull Base | 1 | 2004 | 306 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2007 | 2649 | 0.010 |
Why?
|
| Glycine | 1 | 2004 | 671 | 0.010 |
Why?
|
| Point Mutation | 1 | 2005 | 1623 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2007 | 2715 | 0.010 |
Why?
|
| Middle Aged | 4 | 2016 | 213383 | 0.010 |
Why?
|
| Registries | 1 | 2015 | 8089 | 0.010 |
Why?
|
| Boston | 1 | 2012 | 9313 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2007 | 2751 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2007 | 1788 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2004 | 1997 | 0.010 |
Why?
|
| Family Health | 1 | 2004 | 1282 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 15540 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 1903 | 0.010 |
Why?
|
| Sample Size | 1 | 2001 | 845 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 15519 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 3508 | 0.010 |
Why?
|
| Models, Neurological | 1 | 2006 | 1774 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 2916 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2006 | 19905 | 0.010 |
Why?
|
| United States | 2 | 2013 | 69872 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2012 | 4468 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2012 | 12720 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39050 | 0.010 |
Why?
|
| Pedigree | 1 | 2001 | 4644 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 3494 | 0.010 |
Why?
|
| Prognosis | 1 | 2013 | 29063 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 25043 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 14557 | 0.010 |
Why?
|
| Sex Factors | 1 | 2005 | 10397 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2007 | 6544 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2006 | 4043 | 0.010 |
Why?
|
| Patient Selection | 1 | 2001 | 4215 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2005 | 23338 | 0.000 |
Why?
|
| Pregnancy | 1 | 2005 | 29144 | 0.000 |
Why?
|
| Mice | 1 | 2007 | 81183 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 57776 | 0.000 |
Why?
|
| Animals | 1 | 2007 | 168757 | 0.000 |
Why?
|
| Aged | 1 | 2004 | 163280 | 0.000 |
Why?
|